May 6, 2020administration, aid, analysis, analytics, and Economic Security Act, assistance, business, Business Analysis, cannabis, CARES Act, cbd, CBDMd, companies, compliance, controlled substance, Coronavirus, COVID, COVID-19, cultivation, CV Sciences, Dispensaries & Retail, dispensary, extraction, Federal, financial, government, growing, hemp, industry, law, legal, legalization, legalize, legislation, license, lifted made, marijuana, market, MED, medical, medicine, money, pandemic, PPP, product, products, Quality, rec, recreational, regulation, regulations, regulatory, relief, SBA, schedule, schedule 1, small, state, thc, Trump, VICE Some CBD Companies Are Getting Millions in Federal Aid As we’ve covered previously, the coronavirus pandemic has impacted the cannabis industry in the United States in a number of ways. Many […]